– the leading provider of online annual reports to individual and institutional investors.

Achillion Pharmaceuticals Inc.

Achillion Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports